相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Efficacy of statins in treatment and development of non-alcoholic fatty liver disease and steatohepatitis: A systematic review and meta-analysis
Kaneez Fatima et al.
CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY (2022)
Prevalence, Diagnosis, and Treatment with 3 Different Statins of Non-alco- holic Fatty Liver Disease/Non-alcoholic Steatohepatitis in Military Person- nel. Do Genetics Play a Role?
Georgios Sfikas et al.
CURRENT VASCULAR PHARMACOLOGY (2021)
Treatments for NAFLD: State of Art
Alessandro Mantovani et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Addressing the epidemic of fatty liver disease: A call to action, a call to collaboration, a call to moving the field forward
Chrysoula Boutari et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2021)
The progression and regression of metabolic dysfunction-associated fatty liver disease are associated with the development of subclinical atherosclerosis: A prospective analysis
Shanshan Liu et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2021)
Current and emerging pharmacological options for the treatment of nonalcoholic steatohepatitis
Stergios A. Polyzos et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2020)
Statins and nonalcoholic fatty liver disease in the era of precision medicine: More friends than foes
Fabio Nascimbeni et al.
ATHEROSCLEROSIS (2019)
Comprehensive evaluation of effects and safety of statin on the progression of liver cirrhosis: a systematic review and meta-analysis
Yue Gu et al.
BMC GASTROENTEROLOGY (2019)
The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
Naga Chalasani et al.
HEPATOLOGY (2018)
Predictors of advanced fibrosis in non-cirrhotic non-alcoholic fatty liver disease in Germany
Christian Labenz et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2018)
Statin use and histopathological change in patients with non-alcoholic fatty liver disease: a systematic review and meta-analysis
Pakkapon Rattanachaisit et al.
ASIAN BIOMEDICINE (2018)
Under-prescription of statins in patients with non-alcoholic fatty liver disease
M. Del Ben et al.
NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES (2017)
Evaluating the Impact and Cost-Effectiveness of Statin Use Guidelines for Primary Prevention of Coronary Heart Disease and Stroke
David J. Heller et al.
CIRCULATION (2017)
Statins and portal hypertension: A tale of two models
Juan P. Arab et al.
HEPATOLOGY (2016)
EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease
Giulio Marchesini et al.
JOURNAL OF HEPATOLOGY (2016)
Non-alcoholic fatty liver disease and risk of incident cardiovascular disease: A meta-analysis
Giovanni Targher et al.
JOURNAL OF HEPATOLOGY (2016)
Non-alcoholic fatty liver disease and risk of cardiovascular disease
Amedeo Lonardo et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2016)
Statins, antidiabetic medications and liver histology in patients with diabetes with non-alcoholic fatty liver disease
Fabio Nascimbeni et al.
BMJ OPEN GASTROENTEROLOGY (2016)
Fibrosis Progression in Nonalcoholic Fatty Liver vs Nonalcoholic Steatohepatitis: A Systematic Review and Meta-analysis of Paired-Biopsy Studies
Siddharth Singh et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2015)
The efficacy and safety of statins for the treatment of non-alcoholic fatty liver disease
Daniele Pastori et al.
DIGESTIVE AND LIVER DISEASE (2015)
Epidemiological modifiers of non-alcoholic fatty liver disease: Focus on high-risk groups
Amedeo Lonardo et al.
DIGESTIVE AND LIVER DISEASE (2015)
Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease
Paul Angulo et al.
GASTROENTEROLOGY (2015)
Statin use and non-alcoholic steatohepatitis in at risk individuals
Paola Dongiovanni et al.
JOURNAL OF HEPATOLOGY (2015)
Resolution of non-alcoholic steatohepatitis by rosuvastatin monotherapy in patients with metabolic syndrome
Konstantinos Kargiotis et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2015)
Prevalence of Nonalcoholic Fatty Liver Disease in the United States: The Third National Health and Nutrition Examination Survey, 1988-1994
Mariana Lazo et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2013)
Effect of intensive lipid lowering with atorvastatin on cardiovascular outcomes in coronary heart disease patients with mild-to-moderate baseline elevations in alanine aminotransferase levels
Matti J. Tikkanen et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2013)
Atorvastatin improves disease activity of nonalcoholic steatohepatitis partly through its tumour necrosis factor-α-lowering property
Hideyuki Hyogo et al.
DIGESTIVE AND LIVER DISEASE (2012)
Efficacy of rosuvastatin for the treatment of non-alcoholic steatohepatitis with dyslipidemia: An open-label, pilot study
Takashi Nakahara et al.
HEPATOLOGY RESEARCH (2012)
Lipid Targets During Statin Treatment in Dyslipidemic Patients Affected by Nonalcoholic Fatty Liver Disease
Lorenzo Maroni et al.
AMERICAN JOURNAL OF THE MEDICAL SCIENCES (2011)
Changes in the Prevalence of the Most Common Causes of Chronic Liver Diseases in the United States From 1988 to 2008
Zobair M. Younossi et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2011)
Assessing The Treatment Effect in Metabolic Syndrome Without Perceptible Diabetes (ATTEMPT): A Prospective-Randomized Study in Middle Aged Men and Women
Vassilios G. Athyros et al.
Current Vascular Pharmacology (2011)
Prevalence of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis Among a Largely Middle-Aged Population Utilizing Ultrasound and Liver Biopsy: A Prospective Study
Christopher D. Williams et al.
GASTROENTEROLOGY (2011)
Efficacy of pitavastatin for the treatment of non-alcoholic steatohepatitis with dyslipidemia: An open-label, pilot study
Hideyuki Hyogo et al.
HEPATOLOGY RESEARCH (2011)
Hepatotoxicity Fears Contribute to Underutilization of Statin Medications by Primary Care Physicians
Fadi S. Rzouq et al.
AMERICAN JOURNAL OF THE MEDICAL SCIENCES (2010)
Safety and efficacy of long-term statin treatment for cardiovascular events in patients with coronary heart disease and abnormal liver tests in the Greek Atorvastatin and Coronary Heart Disease Evaluation (GREACE) Study: a post-hoc analysis
Vasilios G. Athyros et al.
LANCET (2010)
Risk of Cardiovascular Disease in Patients with Nonalcoholic Fatty Liver Disease
Giovanni Targher et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
A Pilot Study Using Simvastatin in the Treatment of Nonalcoholic Steatohepatitis A Randomized Placebo-controlled Trial
Austin Nelson et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2009)
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration
Alessandro Liberati et al.
BMJ-BRITISH MEDICAL JOURNAL (2009)
Efficacy of atorvastatin for the treatment of nonalcoholic steatohepatitis with dyslipidemia
Hideyuki Hyogo et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2008)
Abnormalities of Lipid Metabolism in Nonalcoholic Fatty Liver Disease
Onpan Cheung et al.
SEMINARS IN LIVER DISEASE (2008)
Significant correlations between severe fatty liver and risk factors for metabolic syndrome
Pi-Jung Hsiao et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2007)
Impact of statin dosing intensity on transaminase and creatine kinase
Krista M. Dale et al.
AMERICAN JOURNAL OF MEDICINE (2007)
Statins in non-alcoholic fatty liver disease and chronically elevated liver enzymes:: A histopathological follow-up study
Mattlas Ekstedt et al.
JOURNAL OF HEPATOLOGY (2007)
The NAFLD fibrosis score: A noninvasive system that identifies liver fibrosis in patients with NAFLD
Paul Angulo et al.
HEPATOLOGY (2007)
Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection
Richard K. Sterling et al.
HEPATOLOGY (2006)
Assessing heterogeneity in meta-analysis:: Q statistic or I2 index?
Tania B. Huedo-Medina et al.
PSYCHOLOGICAL METHODS (2006)
Effect of multifactorial treatment on non-alcoholic fatty liver disease in metabolic syndrome: a randomised study
Vasilios G. Athyros et al.
CURRENT MEDICAL RESEARCH AND OPINION (2006)
Rosuvastatin: A safe and effective treatment for dyslipidaemia associated with non-alcoholic steatohepatitis (NASH)
MH Ahmed
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2006)
Design and validation of a histological scoring system for nonalcoholic fatty liver disease
DE Kleiner et al.
HEPATOLOGY (2005)
Statins and hepatotoxicity: Focus on patients with fatty liver
N Chalasani
HEPATOLOGY (2005)
Statins and liver toxicity: A meta-analysis
S de Denus et al.
PHARMACOTHERAPY (2004)
Patients with elevated liver enzymes are not at higher risk for statin hepatotoxicity
N Chalasani et al.
GASTROENTEROLOGY (2004)
Ursodeoxycholic acid and atorvastatin in the treatment of nonalcoholic steatohepatitis
M Kiyici et al.
CANADIAN JOURNAL OF GASTROENTEROLOGY (2003)
Nonalcoholic steatohepatitis: Association of insulin resistance and mitochondrial abnormalities
AJ Sanyal et al.
GASTROENTEROLOGY (2001)
Nonalcoholic steatohepatitis: Definition and pathology
EM Brunt
SEMINARS IN LIVER DISEASE (2001)
Short- and long-term effects of atorvastatin, lovastatin and simvastatin on the cellular metabolism of cholesteryl esters and VLDL secretion in rat hepatocytes
E Isusi et al.
ATHEROSCLEROSIS (2000)
分享论文
